Mitral stenosis prevention: Difference between revisions
| Line 7: | Line 7: | ||
==Primary Prevention== | ==Primary Prevention== | ||
Effective measures for the primary [[Prevention (medical)|prevention]] of mitral stenosis include preventing of [[endocarditis]] and decreasing new [[patients]] of [[Rheumatic fever|rheumatic fever.]]<ref name="Nkomo2006">{{cite journal|last1=Nkomo|first1=V. T|title=Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa|journal=Heart|volume=93|issue=12|year=2006|pages=1510–1519|issn=1355-6037|doi=10.1136/hrt.2007.118810}}</ref> | Effective measures for the primary [[Prevention (medical)|prevention]] of mitral stenosis include preventing of [[endocarditis]] and decreasing new [[patients]] of [[Rheumatic fever|rheumatic fever.]] Effective measures for the primary [[prevention]] of rheumatic fever include reducing exposure to [[Group A beta-hemolytic streptococci]], which requires dramatic improvements in housing, [[hygiene]] infrastructure and access to health care for individuals in the developing countries. Most [[streptococcal pharyngitis]], when treated with appropriate [[antibiotics]], prevents acute rheumatic fever. Unfortunately, at least one third of episodes of acute rheumatic fever result from unapparent [[streptococcal infections]]. In addition, some [[symptomatic]] [[patients]] do not seek [[medical]] care; in these instances, rheumatic fever is not preventable.<ref name="Nkomo2006">{{cite journal|last1=Nkomo|first1=V. T|title=Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa|journal=Heart|volume=93|issue=12|year=2006|pages=1510–1519|issn=1355-6037|doi=10.1136/hrt.2007.118810}}</ref><ref name="pmid15927077">{{cite journal| author=Robertson KA, Volmink JA, Mayosi BM| title=Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. | journal=BMC Cardiovasc Disord | year= 2005 | volume= 5 | issue= 1 | pages= 11 | pmid=15927077 | doi=10.1186/1471-2261-5-11 | pmc=PMC1164408 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15927077 }}</ref><ref name="pmid15415234">{{cite journal| author=DENNY FW, WANNAMAKER LW, BRINK WR, RAMMELKAMP CH, CUSTER EA| title=Prevention of rheumatic fever; treatment of the preceding streptococcic infection. | journal=J Am Med Assoc | year= 1950 | volume= 143 | issue= 2 | pages= 151-3 | pmid=15415234 | doi= | pmc= | url= }}</ref><ref name="pmid1945592">{{cite journal| author=Dajani AS| title=Current status of nonsuppurative complications of group A streptococci. | journal=Pediatr Infect Dis J | year= 1991 | volume= 10 | issue= 10 Suppl | pages= S25-7 | pmid=1945592 | doi= | pmc= | url= }}</ref> | ||
Effective measures for the primary prevention of [disease name] include: | Effective measures for the primary prevention of [disease name] include: | ||
Revision as of 14:26, 10 April 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Effective measures for the primary prevention of mitral stenosis include preventing of endocarditis and decreasing new patients of rheumatic fever. Effective measures for the primary prevention of rheumatic fever include reducing exposure to Group A beta-hemolytic streptococci and antibiotic prophylaxis for streptococcal pharyngitis. Intramuscular benzathine penicillin G and oral penicillin V are the recommended antibiotics in treatment of group A streptococcal infection in absence of penicillin allergy.
Primary Prevention
Effective measures for the primary prevention of mitral stenosis include preventing of endocarditis and decreasing new patients of rheumatic fever. Effective measures for the primary prevention of rheumatic fever include reducing exposure to Group A beta-hemolytic streptococci, which requires dramatic improvements in housing, hygiene infrastructure and access to health care for individuals in the developing countries. Most streptococcal pharyngitis, when treated with appropriate antibiotics, prevents acute rheumatic fever. Unfortunately, at least one third of episodes of acute rheumatic fever result from unapparent streptococcal infections. In addition, some symptomatic patients do not seek medical care; in these instances, rheumatic fever is not preventable.[1][2][3][4]
Effective measures for the primary prevention of [disease name] include:
- [Measure1]
- [Measure2]
- [Measure3
References
- ↑ Nkomo, V. T (2006). "Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa". Heart. 93 (12): 1510–1519. doi:10.1136/hrt.2007.118810. ISSN 1355-6037.
- ↑ Robertson KA, Volmink JA, Mayosi BM (2005). "Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis". BMC Cardiovasc Disord. 5 (1): 11. doi:10.1186/1471-2261-5-11. PMC 1164408. PMID 15927077.
- ↑ DENNY FW, WANNAMAKER LW, BRINK WR, RAMMELKAMP CH, CUSTER EA (1950). "Prevention of rheumatic fever; treatment of the preceding streptococcic infection". J Am Med Assoc. 143 (2): 151–3. PMID 15415234.
- ↑ Dajani AS (1991). "Current status of nonsuppurative complications of group A streptococci". Pediatr Infect Dis J. 10 (10 Suppl): S25–7. PMID 1945592.